RR

Rajbala Rani

Active Director Director DIN 02273596
DIN 02273596 First appointment Aug 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value •••• Premium profile

About Rajbala Rani

Data last updated:

Rajbala Rani is a Director at Swarn Artificial Aids Private Limited (since 2008). The company operates in Healthcare. Swarn Artificial Aids Private Limited reported revenue of ₹7 Lakh (FY 2025).

DIN 02273596
Primary Designation Director
Industry Healthcare
First Appointment 14 Aug 2008
Oldest Company Age 19 yrs
Largest company Swarn Artificial Aids Private Limited · ₹7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20082007₹7 Lakh (FY 2025)Active

Board colleagues of Rajbala Rani

NameDINCompanyDesignation
Satish Kumar Goel02282956Swarn Artificial Aids Private LimitedDirector

Directorship timeline

Open interactive timeline →
Swarn Artificial Aids Private Limited
Premium access

Shareholding and investment profile for Rajbala Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajbala Rani

Rajbala Rani currently holds 1 directorship: Swarn Artificial Aids Private Limited (Director, since 14 Aug 2008, revenue ₹7 Lakh (FY 2025)).

Rajbala Rani was first appointed on 14 Aug 2008 as Director at Swarn Artificial Aids Private Limited.

The current boards of Rajbala Rani's companies include Satish Kumar Goel (Swarn Artificial Aids Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available